Neuberger Berman Genesis Portfolio HAE Holdings History
Neuberger Berman Genesis Portfolio's Haemonetics Corp Holding Summary
As of 2024-12-31, Brighthouse Funds Trust II held 188,459.00 shares of Haemonetics Corp(HAE), totaling $14.71 Mil. This investment constitutes 1.7% of their stock portfolio, and Brighthouse Funds Trust II now holds 0.38% of the outstanding Haemonetics Corp(HAE) stock.
The initial trade took place in 2019Q3. And since then Neuberger Berman Genesis Portfolio has made 7 purchases of HAE, at an average price of $110.81, for a total of 272,043.00 shares. In addition, there have been 12 sales at an average price of $86.12 for 83,584.00 shares. Based on historical transaction data and HAE's current price of $72.54, Neuberger Berman Genesis Portfolio's estimated gain on his HAE holdings is $-9.28 Mil, reflecting a -30.77% gain to date.
Neuberger Berman Genesis Portfolio HAE ($72.54) Holding Chart
Neuberger Berman Genesis Portfolio HAE ($72.54) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
